Nanalysis Scientific (CVE:NSCI) Reaches New 12-Month Low – What’s Next?
by Danessa Lincoln · The Markets DailyNanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s share price reached a new 52-week low on Wednesday . The company traded as low as C$0.16 and last traded at C$0.17, with a volume of 77287 shares. The stock had previously closed at C$0.17.
Nanalysis Scientific Stock Performance
The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The company has a market capitalization of C$18.95 million, a PE ratio of -1.50 and a beta of -0.82. The stock’s fifty day moving average price is C$0.19 and its two-hundred day moving average price is C$0.22.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
See Also
- Five stocks we like better than Nanalysis Scientific
- Buy P&G Now, Before It Sets A New All-Time High
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- What is a Microcap Stock? Everything You Need to Know
- 3 Stocks You’ll Wish You Bought Before 2026
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Wall Street Punished CrowdStrike for Beating Earnings? Seriously?